[go: up one dir, main page]

DE60132077D1 - Vitaminzusammenstellung mit verzögerter freigabe - Google Patents

Vitaminzusammenstellung mit verzögerter freigabe

Info

Publication number
DE60132077D1
DE60132077D1 DE60132077T DE60132077T DE60132077D1 DE 60132077 D1 DE60132077 D1 DE 60132077D1 DE 60132077 T DE60132077 T DE 60132077T DE 60132077 T DE60132077 T DE 60132077T DE 60132077 D1 DE60132077 D1 DE 60132077D1
Authority
DE
Germany
Prior art keywords
release
medicament
inner core
delayed release
vitamin
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE60132077T
Other languages
English (en)
Other versions
DE60132077T3 (de
DE60132077T2 (de
Inventor
Juergen Block
Stefan Heim
Ralf Westerheide
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
GlaxoSmithKline Consumer Healthcare GmbH and Co KG
Allphamed Pharbil Pharma GmbH
Original Assignee
GlaxoSmithKline Consumer Healthcare GmbH and Co KG
Allphamed Pharbil Pharma GmbH
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=9888515&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DE60132077(D1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by GlaxoSmithKline Consumer Healthcare GmbH and Co KG, Allphamed Pharbil Pharma GmbH filed Critical GlaxoSmithKline Consumer Healthcare GmbH and Co KG
Publication of DE60132077D1 publication Critical patent/DE60132077D1/de
Application granted granted Critical
Publication of DE60132077T2 publication Critical patent/DE60132077T2/de
Publication of DE60132077T3 publication Critical patent/DE60132077T3/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5073—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/15—Vitamins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5005—Wall or coating material
    • A61K9/5015—Organic compounds, e.g. fats, sugars
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Mycology (AREA)
  • Nutrition Science (AREA)
  • Food Science & Technology (AREA)
  • Polymers & Plastics (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Confectionery (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
DE60132077.8T 2000-03-27 2001-03-21 Vitaminzusammenstellung mit verzögerter freigabe Expired - Lifetime DE60132077T3 (de)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
GB0007419 2000-03-27
GBGB0007419.5A GB0007419D0 (en) 2000-03-27 2000-03-27 Composition
PCT/EP2001/003192 WO2001072286A1 (en) 2000-03-27 2001-03-21 Sustained release vitamin composition
EP01927763.1A EP1267844B2 (de) 2000-03-27 2001-03-21 Vitaminzusammenstellung mit verzögerter freigabe

Publications (3)

Publication Number Publication Date
DE60132077D1 true DE60132077D1 (de) 2008-02-07
DE60132077T2 DE60132077T2 (de) 2008-12-18
DE60132077T3 DE60132077T3 (de) 2016-07-14

Family

ID=9888515

Family Applications (1)

Application Number Title Priority Date Filing Date
DE60132077.8T Expired - Lifetime DE60132077T3 (de) 2000-03-27 2001-03-21 Vitaminzusammenstellung mit verzögerter freigabe

Country Status (15)

Country Link
US (1) US7422758B2 (de)
EP (1) EP1267844B2 (de)
KR (1) KR100824104B1 (de)
AT (1) ATE381926T2 (de)
AU (1) AU2001254711A1 (de)
BR (1) BRPI0109575B8 (de)
CZ (1) CZ304818B6 (de)
DE (1) DE60132077T3 (de)
ES (1) ES2298231T5 (de)
GB (1) GB0007419D0 (de)
HU (1) HU230771B1 (de)
MX (1) MXPA02009547A (de)
PL (1) PL202684B1 (de)
RU (1) RU2248200C2 (de)
WO (1) WO2001072286A1 (de)

Families Citing this family (63)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7560123B2 (en) 2004-08-12 2009-07-14 Everett Laboratories, Inc. Compositions and methods for nutrition supplementation
US7985422B2 (en) 2002-08-05 2011-07-26 Torrent Pharmaceuticals Limited Dosage form
US8487002B2 (en) * 2002-10-25 2013-07-16 Paladin Labs Inc. Controlled-release compositions
TWI319713B (en) * 2002-10-25 2010-01-21 Sustained-release tramadol formulations with 24-hour efficacy
US6814983B2 (en) * 2002-12-10 2004-11-09 Everett Laboratories, Inc. Compositions and methods for nutrition supplementation
US8617617B2 (en) 2002-12-10 2013-12-31 Everett Laboratories, Inc. Methods and kits for co-administration of nutritional supplements
US20060172006A1 (en) * 2003-10-10 2006-08-03 Vincent Lenaerts Sustained-release tramadol formulations with 24-hour clinical efficacy
US20050226906A1 (en) * 2004-04-08 2005-10-13 Micro Nutrient, Llc Nutrient system for individualized responsive dosing regimens
US7785619B2 (en) * 2004-04-08 2010-08-31 Micro Nutrient, Llc Pharmanutrient composition(s) and system(s) for individualized, responsive dosing regimens
US8101587B2 (en) 2004-08-12 2012-01-24 Everett Laboratories, Inc. Kits for nutrition supplementation
DE102005011029A1 (de) * 2005-03-08 2006-09-14 Maria Clementine Martin Klosterfrau Vertriebsgesellschaft Mbh Zusammensetzung für die perorale Applikation mit gesteuerter Freisetzung von Wirkstoffen
GB0507167D0 (en) 2005-04-08 2005-05-18 Glaxosmithkline Consumer Healt Composition
JP2009507047A (ja) 2005-09-09 2009-02-19 ラボファーム インコーポレイテッド 持続性薬物放出組成物
WO2007048220A2 (en) * 2005-09-09 2007-05-03 Labopharm Inc. Trazodone composition for once a day adminisitiation
US20070128272A1 (en) * 2005-12-07 2007-06-07 Zerbe Horst G Multi-vitamin and mineral supplement
SI1993559T1 (sl) 2006-02-03 2017-01-31 Opko Renal, Llc Zdravljenje nezadostnosti in pomanjkanja vitamina D s 25-hidroksivitaminon D2 in 25-hidroksivitaminom D3
PT2679228T (pt) 2006-06-21 2018-04-16 Opko Ireland Global Holdings Ltd Terapia utilizando um agente de repleção de vitamina d e um agente de substituição hormonal de vitamina d
US8491937B2 (en) * 2007-02-15 2013-07-23 Wyeth Llc Stability in vitamin and mineral supplements
CA2718571A1 (en) * 2007-03-12 2008-09-18 Pipex Pharmaceuticals, Inc. Oral zinc medicants useful for safely lowering free copper absorption and free copper levels
KR101959952B1 (ko) 2007-04-25 2019-03-19 사이토크로마 인코포레이티드 비타민 ｄ 화합물과 밀랍성 담체를 포함하는 경구 조절성 방출 조성물
EP3225243B1 (de) 2007-04-25 2025-09-03 Opko Renal, LLC Verfahren zur sicheren und effektiven behandlung und vorbeugung von sekundärem hyperparathyroidismus für chronische nierenerkrankung
CN104257667B (zh) 2007-04-25 2019-06-04 欧普科Ip 控股Ii 有限公司 治疗维生素d不足和缺乏、继发性甲状旁腺功能亢进症和维生素d-响应疾病的方法和组合物
DE102007027435A1 (de) * 2007-06-14 2008-12-18 X-Fab Semiconductor Foundries Ag Verfahren und Vorrichtung zur strukturierten Schichtabscheidung auf prozessierten Mikrosystemtechnikwafern
IL187159A0 (en) * 2007-07-03 2009-02-11 Gur Megiddo Use of metadoxine in relief of alcohol intoxication
US9763989B2 (en) 2007-08-03 2017-09-19 Shaklee Corporation Nutritional supplement system
WO2009035496A1 (en) * 2007-08-03 2009-03-19 Shaklee Corporation Nutritional dosage unit
US20090181084A1 (en) * 2008-01-15 2009-07-16 Ta-Ping Liao Oral fast-disintegrating tablet including particles of slowly-releaseable ascorbic acid
CN106853250A (zh) 2008-04-02 2017-06-16 赛特克罗公司 用于维生素d缺乏症和相关障碍的方法、组合物、用途和试剂盒
EP2323735A1 (de) 2008-07-29 2011-05-25 Alcobra Ltd. Substituierte pyridoxin-lactam-carboxylat-salze
WO2010099508A1 (en) 2009-02-26 2010-09-02 Theraquest Biosciences, Inc. Extended release oral pharmaceutical compositions of 3-hydroxy-n-methylmorphinan and method of use
CA2766107A1 (en) * 2009-06-25 2010-12-29 Alcobra Ltd. A method for the treatment, alleviation of symptoms of, relieving, improving and preventing a cognitive disease, disorder or condition
US8545892B2 (en) 2009-06-26 2013-10-01 Nano Pharmaceutical Laboratories, Llc Sustained release beads and suspensions including the same for sustained delivery of active ingredients
US20110091618A1 (en) * 2009-10-16 2011-04-21 Frito-Lay North America, Inc. Method for preventing oxidation and off flavors in high carotenoid foods
AU2010309784B2 (en) * 2009-10-20 2016-11-10 Herbonis Ag Composition comprising Solanum glaucophyllum for preventing and/or treating hypocalcaemia and for stabilizing blood calcium levels
ES2783980T3 (es) 2010-03-29 2020-09-21 Opko Ireland Global Holdings Ltd Métodos y composiciones para la reducción de niveles de paratiroides
RU2423108C1 (ru) * 2010-04-12 2011-07-10 Михаил Иванович Лазарев Оптимизированный витаминно-минеральный комплекс
US8183227B1 (en) 2011-07-07 2012-05-22 Chemo S. A. France Compositions, kits and methods for nutrition supplementation
US8168611B1 (en) 2011-09-29 2012-05-01 Chemo S.A. France Compositions, kits and methods for nutrition supplementation
DE202011109556U1 (de) 2011-10-24 2012-10-29 Maria Clementine Martin Klosterfrau Vertriebsgesellschaft Mbh Eisenhaltige Vitaminzusammensetzung
US20150351438A1 (en) * 2013-01-29 2015-12-10 Otc Nutrition Llc Micronutrient Fortification Delivery
KR101847947B1 (ko) 2013-03-15 2018-05-28 옵코 아이피 홀딩스 Ⅱ 인코포레이티드 안정화되고 변형된 비타민 ｄ 방출 제형
WO2014200347A1 (en) * 2013-06-14 2014-12-18 Ferring B.V. Extended release nicotinamide formulation
TW201618783A (zh) 2014-08-07 2016-06-01 艾森塔製藥公司 以布魯頓(Bruton)氏酪胺酸激酶(BTK)佔據和BTK再合成速率為基礎之治療癌症、免疫和自體免疫疾病及發炎性疾病之方法
US10220047B2 (en) 2014-08-07 2019-03-05 Opko Ireland Global Holdings, Ltd. Adjunctive therapy with 25-hydroxyvitamin D and articles therefor
KR20160050405A (ko) * 2014-10-29 2016-05-11 가톨릭대학교 산학협력단 지용성 첨가제와 약물을 포함하는 혈관용 약물 방출 풍선 및 이의 제조방법
AU2016205282A1 (en) * 2015-01-07 2017-06-29 Corr-Jensen Inc. Compositions and methods for enhancing athletic performance
EP3244881A4 (de) * 2015-01-12 2018-08-15 Nano Pharmaceutical Laboratories LLC Geschichtete mikrokugeln mit verzögerter freisetzung und verfahren zur herstellung davon
US20180368458A1 (en) * 2016-02-17 2018-12-27 Corr-Jensen Inc. Time release vitamins and minerals in edible oils
MY198547A (en) 2016-03-28 2023-09-04 Opko Ireland Global Holdings Ltd Methods of vitamin d treatment
CA3021066C (en) 2016-04-19 2024-04-09 Ferring B.V. Oral pharmaceutical compositions of nicotinamide
CN109069475B (zh) 2016-04-22 2022-01-28 受体控股公司 快速作用植物类医药化合物和营养补剂
EA201892396A1 (ru) 2016-12-02 2019-04-30 Ресептор Лайф Сайенсиз, Инк. Быстродействующие растительные лекарственные соединения и биологически активные добавки
TR201702630A2 (tr) 2017-02-22 2018-09-21 Montero Gida Sanayi Ve Ticaret Anonim Sirketi Alfa li̇poi̇k asi̇t ve suda çözünür vi̇tami̇nler i̇çeren oral farmasöti̇k bi̇leşi̇mler
CN107375711B (zh) * 2017-08-25 2020-11-03 贵州盛茂白芨开发有限公司 一种白芨含片
DE202018101110U1 (de) 2018-02-28 2019-06-03 Omnivision Gmbh Einfach einzunehmende AREDS2-Medikation
UY38480A (es) 2018-11-19 2020-06-30 Receptor Holdings Inc Aminoácidos grasos n-acilados para reducir la variabilidad de absorción en composiciones a base de cannabinoides
EP3962463A1 (de) * 2019-04-30 2022-03-09 DSM IP Assets B.V. Neues abgabesystem für bestimmte wasserlösliche vitamine
AR118962A1 (es) * 2019-05-22 2021-11-10 Bayer Consumer Care Ag Preparaciones de cápsulas de gelatina blanda de vitaminas y minerales que comprenden vitamina c en forma de una sal de ascorbato
EP4054348A1 (de) * 2019-12-10 2022-09-14 Capsugel Belgium NV Partikel mit einem lipid-matrix-kern und einem wirkstoff
TR202014936A2 (tr) 2020-09-21 2022-03-21 Sanovel Ilac Sanayi Ve Ticaret Anonim Sirketi Alfa li̇poi̇k asi̇t ve en az bi̇r b vi̇tami̇ni̇ i̇çeren bi̇r çi̇ft katmanli farmasöti̇k tablet
CN118946346A (zh) * 2022-03-11 2024-11-12 百尔康公司 剂型内包衣和其应用
CN116459221B (zh) * 2022-10-27 2024-11-19 泓博元生命科技（深圳）有限公司 一种提高nad+衍生物生物利用度的方法
WO2025132557A1 (en) * 2023-12-20 2025-06-26 Lesaffre Et Compagnie Solid formulations of tetrahydrofolates

Family Cites Families (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB800973A (en) † 1954-08-13 1958-09-03 Sterling Drug Inc Improvements in or relating to pills or tablets
US2928770A (en) † 1958-11-28 1960-03-15 Frank M Bardani Sustained action pill
US3577512A (en) † 1968-10-11 1971-05-04 Nat Patent Dev Corp Sustained release tablets
US3939259A (en) 1974-05-24 1976-02-17 Anthony Pescetti Coating composition and therapeutic preparation incorporating same
DE3403329A1 (de) † 1984-02-01 1985-08-01 Horst Dr. 4019 Monheim Zerbe Pharmazeutisches produkt in form von pellets mit kontinuierlicher, verzoegerter wirkstoffabgabe
EP0208362A1 (de) * 1985-06-28 1987-01-14 The Procter & Gamble Company Diätetische Zusatzmittel, enthaltend Eisen sowie mit darmlöslicher Schicht ummanteltes Calcium
JPS62103012A (ja) † 1985-10-23 1987-05-13 Eisai Co Ltd 多重顆粒
AU591248B2 (en) † 1986-03-27 1989-11-30 Kinaform Technology, Inc. Sustained-release pharaceutical preparation
US4752479A (en) † 1986-05-27 1988-06-21 Ciba-Geigy Corporaton Multi vitamin and mineral dietary supplement with controlled release bioavailable iron
US4808413A (en) * 1987-04-28 1989-02-28 E. R. Squibb & Sons, Inc. Pharmaceutical compositions in the form of beadlets and method
GB8711256D0 (en) * 1987-05-13 1987-06-17 Unilever Plc Protection
US5049394A (en) * 1987-09-11 1991-09-17 E. R. Squibb & Sons, Inc. Pharmaceutical composition containing high drug load and method for preparing same
JP2643222B2 (ja) 1988-02-03 1997-08-20 エーザイ株式会社 多重層顆粒
US5026559A (en) † 1989-04-03 1991-06-25 Kinaform Technology, Inc. Sustained-release pharmaceutical preparation
US5158777A (en) * 1990-02-16 1992-10-27 E. R. Squibb & Sons, Inc. Captopril formulation providing increased duration of activity
DE4112464A1 (de) † 1991-04-17 1992-10-22 Henkel Kgaa Verbesserte retard-systeme fuer die zeitverzoegerte freigabe medizinischer und/oder biologischer wertstoffe aus einem depot-traegermaterial
GB9117361D0 (en) † 1991-08-12 1991-09-25 Euro Celtique Sa Oral dosage form
US5472712A (en) † 1991-12-24 1995-12-05 Euroceltique, S.A. Controlled-release formulations coated with aqueous dispersions of ethylcellulose
HU213407B (en) * 1993-12-09 1997-06-30 Egyt Gyogyszervegyeszeti Gyar Process for producing tablet with diffusive-osmotic release
US5869084A (en) * 1994-06-20 1999-02-09 K-V Pharmaceuticals Co. Multi-vitamin and mineral supplements for women
DE19718012C1 (de) † 1997-04-29 1998-10-08 Jenapharm Gmbh Verfahren zur Herstellung peroral anwendbarer fester Arzneiformen mit gesteuerter Wirkstoffabgabe
EP0914098B1 (de) * 1997-05-30 2003-10-01 Osmotica Corp. Mehrlagige osmosevorrichtung
US6419960B1 (en) * 1998-12-17 2002-07-16 Euro-Celtique S.A. Controlled release formulations having rapid onset and rapid decline of effective plasma drug concentrations

Also Published As

Publication number Publication date
BRPI0109575B1 (pt) 2016-06-07
BR0109575A (pt) 2003-04-15
DE60132077T3 (de) 2016-07-14
ES2298231T5 (es) 2016-06-08
ES2298231T3 (es) 2008-05-16
ATE381926T2 (de) 2008-01-15
MXPA02009547A (es) 2004-07-30
CZ20023247A3 (cs) 2003-04-16
DE60132077T2 (de) 2008-12-18
AU2001254711A1 (en) 2001-10-08
US20030148992A1 (en) 2003-08-07
US7422758B2 (en) 2008-09-09
CZ304818B6 (cs) 2014-11-19
KR20030020267A (ko) 2003-03-08
EP1267844B1 (de) 2007-12-26
GB0007419D0 (en) 2000-05-17
PL359663A1 (en) 2004-08-23
PL202684B1 (pl) 2009-07-31
KR100824104B1 (ko) 2008-04-21
HUP0300373A2 (hu) 2003-06-28
BRPI0109575B8 (pt) 2021-05-25
WO2001072286A1 (en) 2001-10-04
EP1267844B2 (de) 2016-04-13
EP1267844A1 (de) 2003-01-02
RU2248200C2 (ru) 2005-03-20
HU230771B1 (hu) 2018-03-28
HUP0300373A3 (en) 2005-03-29

Similar Documents

Publication Publication Date Title
DE60132077D1 (de) Vitaminzusammenstellung mit verzögerter freigabe
WO2004056337A3 (en) Oral dosage forms with therapeutically active agents in controlled release cores and immediate release gelatin capsule coats
HRP20060147B1 (hr) Terapijski sustav s kontroliranim otpuštanjem za nazalnu primjenu
ATE216220T1 (de) Osmotische darreichungsform mit zwei mantelschichten
HRP20040323C1 (hr) Oralni oblici davanja propiverina ili njegovih farmaceutski prihvatljivih soli s produljenim oslobađanjem djelotvone supstance
SE9704869D0 (sv) New pharmaceutical formulaton II
NO20011471D0 (no) Nye orale vedvarende frigivelsesformuleringer
AP1954A (en) Controlled release compositions comprising nimesulide.
AU2003274681A1 (en) Dosage form comprising high dose high soluble active ingredient as modified release and low dose active ingredient as immediate release
DE60028710D1 (de) Orale Dosiszusammensetzung mit verlängerter Freigabe
DE69925639D1 (de) Glicazidhaltige matrixtablette mit verzögerter wirkstoffverabreichung zur oralen anwendung
WO2004064815A8 (en) Oral dosage formulation
DE69923336D1 (de) Oral anzuwendende buprenorphinhaltige arzneimittel
DE59907481D1 (de) Kontrolliert freisetzende pharmazeutische zusammensetzung mit tilidinmesylat als wirkstoff
NO20045385L (no) Farmasoytisk preparat inneholdende okskarbazepin med kontrollert frigivelse av aktivt stoff
HRP20010684B1 (hr) Izravno stlaciva matrica za kontrolirano otpustanje jednostruke dnevne doze klaritromicina
WO2002024203A3 (en) Controlled release formulations for oral administration
BR0112847A (pt) Uso de uma forma de dosagem sólida
ATE347358T1 (de) Schwimmende orale formulierungen mit kontrollierter freisetzung von betain
FI20000780L (fi) Peroraalinen lääkemuoto lääkeaineen hallituksi vapauttamiseksi
AR036321A1 (es) Metodo y formulacion farmaceutica para el tratamiento de la discinesia de aparicion tardia.
TR200200683T2 (tr) Oral kontrollü salıverme formülasyonları.
IS7383A (is) Skammtaform með stýrða lyflosun til inngjafar
DE69914472D1 (de) Levosimendanhaltige oral anzuwendende arzneimittel mit gesteuerter wirkstoffverabreichung
DK0615439T3 (da) Iburprofenholdigt retard-lægemiddel og dets anvendelse

Legal Events

Date Code Title Description
8381 Inventor (new situation)

Inventor name: BLOCK, JUERGEN, 33605 BIELEFELD, DE

Inventor name: HEIM, STEFAN, 71083 HERRENBERG, DE

Inventor name: WESTERHEIDE, RALF, 33605 BIELEFELD, DE

8363 Opposition against the patent